Gene · 10019
Papers2,160
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,160
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FABIO: TWAS fine-mapping to prioritize causal genes for binary traits. | PLoS Genet | 2024 | 39621803 | PubTator, text mining | PubMed |
| [Childhood acute lymphoblastic leukemia with CREBBP gene mutation: a clinical analysis of 14 cases]. | Zhongguo Dang Dai Er Ke Za Zhi | 2024 | 39587751 | PubTator, text mining | PubMed |
| Fine-mapping and molecular characterisation of primary sclerosing cholangitis genetic risk loci. | Nat Commun | 2024 | 39505854 | PubTator, text mining | PubMed |
| Germline genetic variants that predispose to myeloproliferative neoplasms and hereditary myeloproliferative phenotypes. | Leuk Res | 2024 | 39316992 | PubTator, text mining | PubMed |
| Clinical and genetic profile of Chinese patients with indolent natural killer-cell lymphoproliferative disorder of the gastrointestinal tract. | Neoplasia | 2024 | 39276532 | PubTator, text mining | PubMed |
| [Genetic Variation of SH2B3 in Patients with Myeloid Neoplasms]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2024 | 39192417 | PubTator, text mining | PubMed |
| Genetic relations between type 1 diabetes, coronary artery disease and leukocyte counts. | Diabetologia | 2024 | 39141130 | PubTator, text mining | PubMed |
| Proteome- and Transcriptome-Wide Genetic Analysis Identifies Biological Pathways and Candidate Drug Targets for Preeclampsia. | Circ Genom Precis Med | 2024 | 39119725 | PubTator, text mining | PubMed |
| Control of germinal center B cell survival and IgE production by an adaptor molecule containing PH and SH2 domains, Aps/Sh2b2. | Sci Rep | 2024 | 39090233 | PubTator, text mining | PubMed |
| Novel genetic association between obesity, colorectal cancer, and inflammatory bowel disease. | J Diabetes Metab Disord | 2024 | 38932827 | PubTator, text mining | PubMed |
| Null-type SH2B3 mutations are potential drivers in a subset of Ph-negative myeloproliferative neoplasms. | Am J Hematol | 2024 | 38924136 | PubTator, text mining | PubMed |
| Establishment and validation of a gene mutation-based risk model for predicting prognosis and therapy response in acute myeloid leukemia. | Heliyon | 2024 | 38831838 | PubTator, text mining | PubMed |
| Analysis of somatic mutations in whole blood from 200,618 individuals identifies pervasive positive selection and novel drivers of clonal hematopoiesis. | Nat Genet | 2024 | 38744975 | PubTator, text mining | PubMed |
| Negative regulation of SH2B3 by SMYD5 controls epithelial-mesenchymal transition in lung cancer. | Mol Cells | 2024 | 38723947 | PubTator, text mining | PubMed |
| Clinical laboratory characteristics and gene mutation spectrum of Ph-negative MPN patients with atypical variants of JAK2, MPL, or CALR. | Cancer Med | 2024 | 38618943 | PubTator, text mining | PubMed |
| SH2B3 alterations in a novel genetic condition, juvenile myelomonocytic leukemia, and myeloproliferative neoplasia. | Haematologica | 2024 | 38618667 | PubTator, text mining | PubMed |
| Diagnostic Approaches to Investigate JAK2-Unmutated Erythrocytosis Based on a Single Tertiary Center Experience. | Mol Diagn Ther | 2024 | 38568469 | PubTator, text mining | PubMed |
| The role of longevity-related genetic variant interactions as predictors of survival after 85 years of age. | Mech Ageing Dev | 2024 | 38484896 | PubTator, text mining | PubMed |
| A multi-ancestry genome-wide association study in type 1 diabetes. | Hum Mol Genet | 2024 | 38453145 | PubTator, text mining | PubMed |
| Monogenic lupus: insights into disease pathogenesis and therapeutic opportunities. | Curr Opin Rheumatol | 2024 | 38420886 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10019/papers?page=5